Union Bancaire Privee UBP SA nearly doubled down on Marsh & McLennan, boosting its stake by an eyebrow-raising 139.8% in Q1.

Boston Scientific appears to be flexing a premium price tag that’s a bit too buff for its own balance sheet. Analysts using a ...

Harbor Capital Advisors reduced its stake in Southwest Airlines by 22%, selling 2,563 shares during Q1, now holding 9,109 ...

Farther Finance Advisors isn’t just watching PayPal—they’re buying in, upping their stake by 95.6% to $1.01 million. This ...

Arete Research slapped Etsy with a “strong sell” rating, triggering investor panic and a 5.6% drop in share price. Other ...

Mondelez International saw a tasty boost in investor confidence as Ferguson Wellman Capital upped its holdings by 31.2%, ...

Palantir is riding high on AI buzz and investor dreams, with analyst Mark Schappel slapping a record $155 price target on it.

Alibaba Group is once again catching Wall Street’s eye, thanks to a recent upgrade by research analysts at Wall Street Zen.

CVS Health is getting a healthy boost from institutional investors, with Parkside Investments increasing its stake by 36.7% in Q1. Parkside added over 20,000 shares, bringing its total to 76,084 ...

Bristol Myers' Sotyktu, a TYK2 inhibitor already approved for psoriasis, scored a win in a Phase III trial for psoriatic ...

Apple plans to roll out an upgraded Siri by spring 2026 as part of iOS 26.4, turning its assistant into something more ...

Milestone Asset Management slashed its NVIDIA holdings by 21.4% in Q1, reducing its stake to 54,236 shares worth $5.88 ...